27.02.2024 16:08 | VRCI | Holding(s) in Company | RNS |
22.02.2024 07:00 | VRCI | Holding(s) in Company | RNS |
21.02.2024 16:53 | VRCI | Holding(s) in Company | RNS |
21.02.2024 07:00 | VRCI | Holding(s) in Company | RNS |
19.02.2024 12:35 | VRCI | Result of General Meeting | RNS |
14.02.2024 13:19 | VRCI | Verici DX raises GBP280,000 via retail offer, adding to placing raise | Alliance |
14.02.2024 07:00 | VRCI | Result of Retail Offer | RNS |
31.01.2024 21:42 | ASIA, GMAA, PXC | EARNINGS AND TRADING: Asia Strategic loss narrows; Verici Dx grant win | Alliance |
31.01.2024 07:00 | VRCI | Verici Dx announces new research initiative | Reach |
26.01.2024 12:32 | VRCI | Publication of Circular | RNS |
25.01.2024 11:00 | VRCI | Launch of Retail Offer | RNS |
24.01.2024 19:05 | VRCI, WIN, MEN | TRADING UPDATES: Diversified Energy criticises "opportunistic" report | Alliance |
24.01.2024 18:11 | VRCI | Result of Placing | RNS |
24.01.2024 14:09 | VRCI | Verici shares fall after completing discounted GBP5.5 million placing | Alliance |
24.01.2024 10:39 | VRCI | Close of Accelerated Bookbuild | RNS |
24.01.2024 07:00 | VRCI | Proposed Fundraising | RNS |
08.01.2024 10:15 | VRCI | Verici up after US health agency confirms pricing rate for blood tests | Alliance |
08.01.2024 07:00 | VRCI | CAP accreditation | Reach |
08.01.2024 07:00 | VRCI | Medicare National Payment Rate Confirmation | Reach |
11.12.2023 11:58 | VRCI | Verici Dx hails publication of Tutivia data in transplant journal | Alliance |
11.12.2023 07:00 | VRCI | Tutivia™ validation study published in Journal | RNS |
29.11.2023 16:33 | VRCI | Verici gets ISO 27001 seal for information management security system | Alliance |
29.11.2023 07:00 | VRCI | ISO 27001 Information Security Certification | Reach |
20.11.2023 07:00 | VRCI | Investor Presentation | RNS |
15.11.2023 10:51 | VRCI, ALL, AURR | AIM WINNERS & LOSERS: Verici Dx rockets on Thermo Fisher contract | Alliance |
15.11.2023 10:14 | VRCI | Verici Dx shares jump on signing Thermo Fisher assay development deal | Alliance |
15.11.2023 07:00 | VRCI | Commercialisation agreement with Thermo Fisher | RNS |
02.11.2023 07:00 | VRCI | Clarava™ poster to be presented at ASN Kidney Week | Reach |
29.09.2023 11:51 | VRCI, SDX, RTOP | EARNINGS: Ebiquity swings to profit; SDX Energy swings to loss | Alliance |
29.09.2023 07:00 | VRCI | Half-year Report | RNS |
20.07.2023 20:06 | GABI, LIT, DUKE | TRADING UPDATES: Chapel Down sales pop; Serabi output rises | Alliance |
20.07.2023 07:00 | VRCI | CLIA Certificate of Compliance update | Reach |
06.07.2023 07:00 | VRCI | Investor Presentation | RNS |
03.07.2023 10:48 | VRCI, ZIOC, KIBO | AIM WINNERS & LOSERS: Yourgene surges on takeover by Novacyt | Alliance |
03.07.2023 10:36 | VRCI | Verici Dx shares jump after Clarava validated in clinical study | Alliance |
03.07.2023 07:00 | VRCI | Successful clinical validation of Clarava™ | RNS |
29.06.2023 16:57 | VRCI | Result of AGM | RNS |
22.06.2023 15:44 | VRCI, TRR, TXP | UK shareholder meetings calendar - next 7 days | Alliance |
06.06.2023 07:00 | VRCI | Notice of AGM and posting of Annual Report | RNS |
05.06.2023 07:01 | VRCI | 2022 Annual Results | RNS |
05.06.2023 07:00 | VRCI | Proposed US pricing for Tutivia™ | RNS |
31.05.2023 07:00 | VRCI | Notice of Results | RNS |
24.05.2023 07:01 | EKF, VRCI | Update re. EKF distribution of shares in Verici Dx | RNS |
24.05.2023 07:00 | VRCI, EKF | Distribution of shares in Verici Dx plc | RNS |
24.04.2023 07:00 | VRCI | Final results timing | Reach |
28.03.2023 11:05 | VRCI | Second Price Monitoring Extn | RNS |
28.03.2023 11:00 | VRCI | Price Monitoring Extension | RNS |
28.03.2023 09:05 | VRCI | Second Price Monitoring Extn | RNS |
28.03.2023 09:00 | VRCI | Price Monitoring Extension | RNS |
27.03.2023 16:35 | VRCI | Price Monitoring Extension | RNS |
27.03.2023 11:05 | VRCI | Second Price Monitoring Extn | RNS |
27.03.2023 11:00 | VRCI | Price Monitoring Extension | RNS |
22.03.2023 07:00 | VRCI | Operational Update | RNS |
21.03.2023 16:40 | VRCI | Second Price Monitoring Extn | RNS |
21.03.2023 16:35 | VRCI | Price Monitoring Extension | RNS |
13.03.2023 12:18 | VRCI, CSFS, SCLP | SUMMARY: London listings with exposure to Silicon Valley Bank | Alliance |
13.03.2023 07:00 | VRCI | Statement re. Silicon Valley Bank | RNS |
09.03.2023 17:11 | VRCI | Verici Dx wins two key patients in US for Clarava and Tutivia | Alliance |
09.03.2023 07:00 | VRCI | Two key patents granted in the US | RNS |
02.03.2023 19:56 | VRCI | IN BRIEF: Verici Dx gains US compliance certificate in 45 states | Alliance |
02.03.2023 11:14 | VRCI, TLY, POLB | AIM WINNERS & LOSERS: Metal Tiger goes into the Strata but out of AIM | Alliance |
02.03.2023 07:00 | VRCI | CLIA Certificate of Compliance | RNS |
27.02.2023 14:00 | VRCI | Price Monitoring Extension | RNS |
07.12.2022 07:00 | VRCI | Director/PDMR Shareholding | RNS |
01.12.2022 18:07 | VRCI | Correction: Holding(s) in Company | RNS |
03.10.2022 11:01 | VRCI | IN BRIEF: Verici shares drop amid Tutivia rebranding ahead of launch | Alliance |
03.10.2022 07:00 | VRCI | Product rebranding as Tutivia™ | Reach |
07.09.2022 12:16 | VRCI | Verici Dx first-half loss widens before launch of commercial products | Alliance |
07.09.2022 07:00 | VRCI | Half-year Report | RNS |
06.09.2022 12:44 | VRCI | Verici Dx shares rise 9% on positive Clarava validation study results | Alliance |
05.09.2022 07:00 | VRCI | Notice of Results | RNS |
02.09.2022 16:41 | VRCI | Second Price Monitoring Extn | RNS |
02.09.2022 16:35 | VRCI | Price Monitoring Extension | RNS |
27.06.2022 15:17 | VRCI | Result of AGM and voting results | RNS |
24.06.2022 07:00 | VRCI | Holding(s) in Company | RNS |